Denali Therapeutics Inc. — Form 10-Q
Filed November 3, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 5/100
What the filing says
Ryan J. Watts (CEO) and Alexander O. Schuth (CFO) certified the Form 10-Q for fiscal period ended September 30, 2026, filed November 3, 2026. Standard SOX 302 and 906 certifications affirming accuracy of financial statements, effectiveness of disclosure controls, and no material weaknesses or fraud in internal controls. No operational changes, financial results, or strategic developments disclosed in these certification exhibits.
Why this rating
Boilerplate SOX certification exhibits; purely administrative attestations. No material facts, numbers, transactions, or operational changes communicated.
See more from November 3, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.